Advertisement
Advertisement
KURA
Kura Oncology, Inc.
11.73
USDSponsored
+0.01
+0.09%
Sep 18, 15:59 UTC -4
Closed
After-Market
11.80
+0.07
+0.61%
KURA Earnings Reports
Positive Surprise Ratio
KURA beat 32 of 43 last estimates.
74%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$24.04M
/-$0.84
Implied change from Q2 26 (Revenue/ EPS)
+15.17%
/+9.09%
Implied change from Q3 25 (Revenue/ EPS)
+15.86%
/-1.18%
Kura Oncology, Inc. earnings per share and revenue
On Aug 12, 2026, KURA reported earnings of -0.77 USD per share (EPS) for Q2 26, beating the estimate of -0.89 USD, resulting in a 13.99% surprise. Revenue reached 20.87 million, compared to an expected 21.85 million, with a -4.46% difference. The market reacted with a +1.51% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of -0.84 USD, with revenue projected to reach 24.04 million USD, implying an increase of 9.09% EPS, and increase of 15.17% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Kura Oncology, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Kura Oncology, Inc. reported EPS of -$0.77, beating estimates by 13.99%, and revenue of $20.87M, -4.46% below expectations.
How did the market react to Kura Oncology, Inc.'s Q2 2026 earnings?
The stock price moved up 1.51%, changed from $9.94 before the earnings release to $10.09 the day after.
When is Kura Oncology, Inc. expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Kura Oncology, Inc.'s next earnings report?
Based on 10
analysts, Kura Oncology, Inc. is expected to report EPS of -$0.84 and revenue of $24.04M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.